Corporate Banner
Satellite Banner
Chromatography
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent Joins Forces with Molecular Discovery

Published: Thursday, September 20, 2012
Last Updated: Thursday, September 20, 2012
Bookmark and Share
Combination of Mass-MetaSite software and high-resolution LC/MS hardware will reduce costs and speed up metabolite identification/analysis.

Agilent Technologies Inc. has announced that it has entered into a comarketing agreement with Molecular Discovery Ltd. to provide biopharmaceutical researchers with an advanced metabolite-identification platform.

The companies will comarket the combined assets of Agilent’s high-resolution liquid chromatography/mass spectrometry (LC/MS) technology and Molecular Discovery’s Mass-MetaSite software to enable superior identification and analysis of complex biological mixtures.

“Until now, the challenges of identifying and predicting human drug metabolism have been major obstacles in the development of safe, effective drug candidates,” said Gus Salem, vice president and general manager of Agilent’s Biological Systems Division.

“Together, Agilent Technologies and Molecular Discovery are working to solve this problem in pharmaceutical research. Whereas traditional metabolite identification, synthesis and toxicity testing has been costly and time consuming for researchers, our combined industry-leading technologies will now give them faster, more accurate data, and the confidence they need to ensure the safety of their products much earlier in the preclinical phase of development.

“For example,” Salem continued, “the Agilent RapidFire 360 product is used to increase sample throughput for pharmaceutical discovery. With Molecular Discovery’s expertise in xenobiotic metabolism and predictive software, the analytical interpretation burden is dramatically reduced. This allows researchers to process the majority of their results automatically and focus their expertise on the more complex cases, streamlining data processing and metabolite identification.”

Gabriele Cruciani, managing director at Molecular Discovery, added, “Agilent’s leading LC/MS platform is enabling companies to obtain high-quality analytical data with a much higher throughput than before. This means that the experts now need to interpret even more data. Working together with Agilent, we are seamlessly combining these high-throughput hardware capabilities with Molecular Discovery’s high-throughput software capabilities, providing a revolutionary advanced metabolite identification platform.”

Metabolites are small molecules that are the products of life in the cells of every type of plant or animal.

Scientists study snapshots of all the metabolites in a given bio-sample in their search for new therapeutics and to understand the mechanisms of disease and health.

Agilent is a world leader in providing sophisticated LC/MS technology for advances in this area.

Prior to the approval of any new drug application, the U. S. Food and Drug Administration requires that all therapeutic compounds be subjected to preclinical metabolic toxicity testing before human clinical trials can begin.

As a primary part of this process, metabolites must be identified and critically assessed to understand how the drug compound will affect human metabolism.

Traditionally, this task has been costly and time consuming for drug makers, and commonly deferred until the final stages of preclinical testing.

This comarketing program provides customers with a turnkey solution that bridges the gap between sophisticated laboratory software and hardware capabilities.

The analytical benefits of Agilent’s high-resolution instruments, integrated with Molecular Discovery’s robust predictive metabolite-identification software tools, will advance drug research and discovery by enabling the decisive identification and conversion of large volumes of data into usable information.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Wins Award for Innovation in LC
Dual-needle technology enhances speed, flexibility.
Thursday, January 28, 2016
Agilent Announces Opening of Life Science Research Center
Facility designed to advance multi-omics research.
Thursday, September 24, 2015
Agilent Technologies and Waters Corporation Formalize Instrument Control Exchange
Agilent Technologies Inc. and Waters Corp have announced a formal agreement to exchange instrument controls to improve the productivity of customers who own software and instruments from both companies.
Wednesday, July 01, 2015
Agilent to Focus on "Powerful Partnerships, Inspiring Results" at ASMS 2015
Company to introduce solutions enabling new standards in mass spectrometry, lab productivity.
Friday, May 29, 2015
Agilent Announces New CEO Mike McMullen
McMullen elected as chief executive officer by Company’s board of directors.
Thursday, March 19, 2015
Utilizing Fast HPLC Screening Methods for the Detection of Steroids
Analysis of steroids improved by choosing the optimal HPLC column for the separation.
Saturday, January 17, 2015
Benefits of SPE for the Analysis of Mycotoxins
Fast and cost-effective sample preparation is essential for the analysis of mycotoxins in food and feed.
Wednesday, January 14, 2015
Agilent Technologies - Making Better GC Connections
Improving GC connections for reliable, robust and reproducible results.
Wednesday, December 24, 2014
How to Achieve High-Speed, High-Resolution Glycan Mapping for mAb Characterization
The full characterization of biotherapeutics is required by regulatory authorities as properties such as safety, efficacy and the serum half-life of therapeutic proteins can be affected by differences in their glycosylation pattern.
Monday, December 22, 2014
Agilent, Bruker Enter Chromatographic Data System Agreement
Instrument driver exchange enhances laboratory efficiency and flexibility.
Saturday, June 21, 2014
Agilent, SISCAPA Sign Protein Quantitation Agreement
Companies sign a non-exclusive agreement to enable SISCAPA to provide an end-to-end solution using a highly automated workflow for LC-MS.
Tuesday, May 27, 2014
Agilent Thought Leader Award Supports Metabolic Research
Princeton team developing LC/MS methods, bioinformatics tools for discovery of metabolic regulatory mechanisms.
Tuesday, April 22, 2014
Agilent, University of Arizona to Host Environmental Analysis Techniques Workshop
Dr. Shane Snyder, EPA Scientists, Leading Environmental Labs to Present Data on Recycled Water, Hydraulic Fracturing, Trace Contaminants in Water.
Monday, March 10, 2014
Agilent, CambTEK Announce LC Sample Prep Agreement
Companies announce agreement to co-market CambTEK's RES automated sample preparation technology with an assortment of Agilent's instruments and software.
Wednesday, February 26, 2014
Agilent's LC/MS Purification System a Winner in Analytical Scientist Innovation Awards
Magazine names 1260 Infinity series one of top 15 game-changing technologies of 2013.
Saturday, February 22, 2014
Scientific News
Determination of 13 Organic Toxicants in Human Blood
Researchers have utilised liquid-liquid extraction coupling HPLC-MS/MS to identify and quantify organic toxicants in human blood.
Massive Helium Discovery a "Game Changer" for Medical Industry
A new development is gas exploration has yielded the discovery of a huge helium gas field, which could help relieve the dwindling supply.
Making Metabolite Identification More Efficient
Metasense combines the industry's most-comprehensive metabolic transformation prediction with efficient analysis of LC/MS analytical measurements to identify, visualize, and report chemical biotransformations.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Origins of Life Delivered from Space
Researchers have for the first time shown that ribose, a sugar that is one of the building blocks of genetic material in living organisms, may have formed in cometary ices.
Protecting Yourself from Mosquitoes Just Got Easier
New GoClip™ from RESCUE!® offers six days of protection from mosquitoes as well as biting flies and ticks.
Structure of Essential Digestive Enzyme Uncovered
Using a powerful combination of techniques from biophysics to mathematics, researchers have revealed new insights into the mechanism of a liver enzyme that is critical for human health.
Why do Tomatoes Smell "Grassy"?
Researchers identify enzymes that convert the grassy smell of tomatoes into a sweeter scent.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!